Skip to main content
. 2018 Apr 11;13:81. doi: 10.1186/s13018-018-0782-5

Table 2.

Distribution and floor/ceiling effects of HAAS-I and other measures in subjects with total hip arthroplasty

Outcome measures Test mean (SD) Re-test mean (SD) Floor/ceiling effects (%)
HAAS 10.50 (3.62) 10.52 (3.42) 0/0 (0%,0%)
WOMAC 17.49 (22.40) n.a. 10/0 (15%,0%)
WOMAC Pain 14.68 (20.81) n.a. 21/0 (31%,0%)
WOMAC Stiffness 19.22 (25.41) n.a. 32/0 (48%,0%)
WOMAC ADL 17.91 (22.91) n.a. 11/0 (16%,0%)
NRS 2.01 (1.86) n.a. 1/0 (2%,0%)
SF-36 Physical Function 67.23 (29.14) n.a. 0/10 (0%,15%)
SF-36 Physical Role 46.30 (44.22) n.a. 27/22 (40%,33%)
SF-36 Bodily Pain 62.06 (30.00) n.a. 3/17 (5%,25%)
SF-36 General health 32.23 (16.90) n.a. 0/0 (0%,0%)
SF-36 Vitality 59.86 (17.42) n.a. 0/0 (0%,0%)
SF-36 Social function 72.38 (23.80) n.a. 0/12 (0%,18%)
SF-36 Emotional Role 65.17 (45.48) n.a. 20/40 (30%,60%)
SF-36 Mental Health 67.00 (21.26) n.a. 0/4 (0%,6%)

n.a. not available, SD standard deviation, ICC intraclass correlation coefficient, CI confidence interval, HAAS-I High-Activity Arthroplasty Score (Italian version), NRS numerical rating scale, WOMAC Western Ontario and McMaster University index, SF-36 Short Form Health Survey 36 items